CGM
CELG

Capital Growth Management’s Celgene Corp CELG Stock Holding History

Capital Growth Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-20,000
Closed -$1.97M – 78
2016
Q2 		$1.97M Buy
+20,000
New +$2.07M 0.09% 45
2015
Q3 		– Sell
-110,000
Closed -$12.7M – 71
2015
Q2 		$12.7M Buy
+110,000
New +$12.6M 0.36% 48

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital Growth Management's CELG Position: Q3 2016 in Review

Capital Growth Management sold out of Celgene Corp (CELG) in Q3 2016, closing a stake of 20,000 shares — an estimated $1.97M sold.

Capital Growth Management first reported a position in CELG in Q2 2015 and held it in 2 quarters. The position peaked at $12.7M in Q2 2015. 1,277 funds tracked by Wall St. Rank hold CELG as of Q3 2016.

  • Capital Growth Management reported no remaining Celgene Corp position as of Q3 2016 after selling out during the quarter.
  • Capital Growth Management sold 20,000 Celgene Corp shares in Q3 2016, an estimated $1.97M.
  • Capital Growth Management first reported a position in Celgene Corp in Q2 2015 and held it in 2 quarters.
  • Capital Growth Management's Celgene Corp position peaked at $12.7M in Q2 2015.
  • 1,277 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2016.

Based on Capital Growth Management's 13F filing for Q3 2016, filed 10 Nov 2016.